Wilson's Disease clinical trials at University of California Health
3 in progress, 0 open to eligible people
Phase 1/2/3 Study of UX701 Gene Therapy in Adults With Wilson Disease
Sorry, in progress, not accepting new patients
The primary objectives of this study are to evaluate the safety of single IV doses of UX701 in patients with Wilson disease, to select the UX701 dose with the best benefit/risk profile based on the totality of safety and efficacy data and to evaluate the effect of UX701 on copper regulation.
at UC Davis UCLA
VTX-801 in Adult Patients With Wilson's Disease
“Become involved in the GATEWAY Clinical Trial (Gene Therapy for Wilson's Disease)”
Sorry, in progress, not accepting new patients
The objectives of this clinical trial are to assess, for up to 5 years, the safety, tolerability and pharmacological activity of a single ascending doses of VTX-801, a gene therapy, administered intravenously (IV) to adult patients with Wilson's Disease prior to and following background WD therapy withdrawal.
at UC Davis
Prescreening Study to Identify Potential Wilson Disease Participants for Gene-Editing Clinical Trial
Sorry, not yet accepting patients
The aim of this study is to inform and improve future clinical trials in Wilson Disease (WD) by better understanding how patients with WD are living with and managing the disease, and by identifying key factors that shape their decisions to participate in clinical research.
at UC Davis UCLA
Last updated: